India warns 'reciprocal measures' on UK vaccine policy

Sep 21, 2021, at 10:32 pm

New Delhi/IBNS: India has iterated its "right to take reciprocal measures" over the UK government's "discriminatory" decision to not recognise Covishield if the matter was not resolved, the government said Tuesday.  

Thai scientists develop robotic arm to draw more AstraZeneca vaccine doses

Aug 26, 2021, at 01:36 am

Bangkok: As Thailand fights its worst-ever Covid-19 outbreak, the scientists in the country have developed a robotic arm that can optimise the use of the coronavirus vaccines, enabling more efficient use of the doses.

AstraZeneca Confirms Shortfall in Planned COVID-19 Vaccine Shipments to EU

Mar 14, 2021, at 01:30 am

Moscow/Sputnik: UK-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has confirmed a shortfall in shipments of its COVID-19 vaccine to the European Union.

AstraZeneca COVID jab 'less effective against South Africa variant': Reports

Feb 08, 2021, at 12:04 am

Johannesburg/UNI: According to reports the COVID-19 vaccine developed by AstraZeneca and the University of Oxford offers only limited protection against the South African variant of the coronavirus, a spokesman for the British drugmaker said here on Sunday.

Oxford vaccine to be 95 pc effective at par with Moderna and Pfizer, says maker AstraZeneca

Dec 28, 2020, at 01:19 am

New Delhi/IBNS: Oxford coronavirus vaccine manufacturer AstraZeneca has claimed that it will shield 95 per cent of the patients and be as effective as Moderna and Pfizer alternatives though the British-Swedish pharma giant is yet to release the data confirming the claim, said media reports.

COVID-19: Oxford vaccine shows 70 percent efficiency 

Nov 23, 2020, at 08:31 pm

London: Oxford University’s AstraZeneca vaccine candidate, AZD1222, which is being developed against COVID-19 disease has shown 70 percent efficiency on average, officials said.

Oxford Vaccine trials resume in UK days after pause over volunteer's illness

Sep 13, 2020, at 02:48 am

London/IBNS: Pharmaceutical giant AstraZeneca on Saturday resumed the trials of Covid-19 vaccine in the United Kingdom after a brief halt following a volunteer's illness, media reports said.

After DCGI's show-cause notice, Serum Institute pauses Covid-19 vaccine trial

Sep 10, 2020, at 11:14 pm

New Delhi/IBNS: Serum Institute of India (SII) on Thursday paused the trial of Covid-19 vaccine a day after it was served a show-cause notice by the Drugs Controller General of India (DCGI) for not informing the central drug regulator about the pause of study testing in other countries, media reports said.

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

Sep 10, 2020, at 04:23 am

New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.